Instil Bio, Inc. TIL
6.61 USD -0.06 (-0.90%)
Nov 4, 2026, 9:48 AM EST
6.60 Day range 6.80
5.56 52-week range 16.00
- YTD
- -39.91%
- 1 year
- -56.40%
Financial health
Altman Z-Score
-4.99 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -1.0×
FY 2019 5y median -1.0× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.6×
FY 2019 5y median 0.6× FY 2025
P/FCF -2.0×
FY 2019 5y median -1.9× FY 2025
EV/EBITDA -2.3×
FY 2019 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -49.9%
FY 2019 5y median -52.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -62.7%
FY 2019 5y median -61.4% FY 2025
ROIC -26.6%
FY 2019 5y median -28.6% FY 2025
ROA -35.1%
FY 2019 5y median -35.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 28.1%
FY 2019 FY 2025
EPS (diluted) 6.1%
FY 2019 FY 2025
Free Cash Flow 44.3%
FY 2019 FY 2025
Financial Health
Current Ratio 39.5×
FY 2019 5y median 15.2× FY 2025
Quick Ratio 39.5×
FY 2019 5y median 15.2× FY 2025
Debt / Equity 0.7×
FY 2019 5y median 0.4× FY 2025
Net Debt / EBITDA -1.2×
FY 2019 5y median -0.5× FY 2025
Interest Coverage -9.1×
FY 2019 5y median -9.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
